Related Experiment Video
Updated: Jun 10, 2026
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
Published on: August 2, 2022
Unlocking the potential of lipid nanoparticles for enhanced glioma therapy: Recent advancements and future
Shiuli Bera1, Shayeri Chatterjee Ganguly1, Priya Manna1
1Department of Pharmaceutical Technology, Brainware University, West Bengal, India.
Abstract:
The most prevalent malignant CNS tumor is glioma, which exhibits a poor survival rate due to several limitations in its successful therapy. The existence of the blood-brain barrier, tumor heterogeneity, complex tumor microenvironment, and glioma stem cells are significant challenges in glioma therapy. This review article provides insight into the major hurdles of glioma therapy. The article's primary focus is to explore lipid nanocarriers' potential role in overcoming these glioma therapy hurdles. Various types of lipid nano-systems have been discussed here. Moreover, this article explains the promise of smart lipid nanoparticles in successful glioma therapy. It also reviews the advanced applications of lipid nanocarriers in glioma, including brain-specific drug delivery, overcoming chemoresistance, radioresistance, and immunotherapy resistance, combined therapy with photodynamic therapy and hyperthermia. This article also highlights the current status of the clinical application of lipid nanoparticles in glioma treatment, emphasizing the need for research in this field to achieve improved therapeutic outcomes for glioma patients.
Insights
Lipid nanocarriers show promise for overcoming major challenges in glioma therapy, including drug delivery and resistance. Further research is needed to improve patient outcomes for this aggressive brain cancer.
Area of Science:
- Neuro-oncology
- Nanomedicine
- Biotechnology
Background:
- Glioma is the most common malignant central nervous system (CNS) tumor with poor survival rates.
- Therapeutic limitations include the blood-brain barrier, tumor heterogeneity, complex microenvironment, and glioma stem cells.
Purpose of the Study:
- To review the challenges in glioma therapy.
- To explore the potential of lipid nanocarriers in overcoming these hurdles.
- To discuss advanced applications and clinical status of lipid nanoparticles in glioma treatment.
Main Methods:
- Literature review of lipid nanocarriers and their applications in glioma therapy.
- Discussion of various lipid nano-systems and smart lipid nanoparticles.
- Analysis of advanced applications including drug delivery and overcoming resistance.
Main Results:
- Lipid nanocarriers offer potential solutions for brain-specific drug delivery.
- Smart lipid nanoparticles show promise in addressing chemoresistance, radioresistance, and immunotherapy resistance.
- Combined therapies with lipid nanocarriers and modalities like photodynamic therapy are explored.
Conclusions:
- Lipid nanocarriers represent a promising strategy for enhancing glioma therapy.
- Advanced applications demonstrate potential for improved treatment outcomes.
- Further clinical research is essential to translate these findings into improved patient care.
More Related Videos
07:25Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
Published on: March 1, 2024
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
